Free Trial
NYSE:FHI

Federated Hermes (FHI) Stock Price, News & Analysis

Federated Hermes logo
$56.00 +0.28 (+0.50%)
As of 02:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Federated Hermes Stock (NYSE:FHI)

Advanced

Key Stats

Today's Range
$54.93
$55.97
50-Day Range
$54.33
$58.30
52-Week Range
$41.55
$59.05
Volume
190,012 shs
Average Volume
759,087 shs
Market Capitalization
$4.25 billion
P/E Ratio
10.86
Dividend Yield
2.71%
Price Target
$54.00
Consensus Rating
Hold

Company Overview

Federated Hermes Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
56th Percentile Overall Score

FHI MarketRank™: 

Federated Hermes scored higher than 56% of companies evaluated by MarketBeat, and ranked 612th out of 887 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Federated Hermes has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no strong buy ratings, 2 buy ratings, 4 hold ratings, and 1 sell rating.

  • Upside/Downside

    The consensus price target for Federated Hermes is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Federated Hermes has only been the subject of 4 research reports in the past 90 days.

  • Read more about Federated Hermes' stock forecast and price target.
  • Earnings Growth

    Earnings for Federated Hermes are expected to grow by 11.22% in the coming year, from $5.08 to $5.65 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Federated Hermes is 10.69, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.26.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Federated Hermes is 10.69, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 23.04.

  • Price to Earnings Growth Ratio

    Federated Hermes has a PEG Ratio of 2.20. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Federated Hermes has a P/B Ratio of 3.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Federated Hermes' valuation and earnings.
  • Percentage of Shares Shorted

    4.98% of the float of Federated Hermes has been sold short.
  • Short Interest Ratio / Days to Cover

    Federated Hermes has a short interest ratio ("days to cover") of 4.18.
  • Change versus previous month

    Short interest in Federated Hermes has recently increased by 14.90%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Federated Hermes pays a meaningful dividend of 2.72%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Federated Hermes has only been increasing its dividend for 4 years.

  • Dividend Coverage

    The dividend payout ratio of Federated Hermes is 29.46%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Federated Hermes will have a dividend payout ratio of 26.90% next year. This indicates that Federated Hermes will be able to sustain or increase its dividend.

  • Read more about Federated Hermes' dividend.
  • News Sentiment

    Federated Hermes has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Federated Hermes this week, compared to 4 articles on an average week.
  • Search Interest

    Only 1 people have searched for FHI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Federated Hermes to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Federated Hermes insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,287,402.00 in company stock.

  • Percentage Held by Insiders

    4.20% of the stock of Federated Hermes is held by insiders.

  • Percentage Held by Institutions

    75.94% of the stock of Federated Hermes is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Federated Hermes' insider trading history.
Receive FHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Federated Hermes and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FHI Stock News Headlines

NNVC FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for NV-387, its antiviral candidate targeting measles - a disease with no approved antiviral treatment and rising global case counts. Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, and Mpox, giving NNVC exposure to multiple large markets as Phase II trials advance. The designation unlocks faster development timelines, financial incentives, and potential market exclusivity.tc pixel
Federated Hermes Earnings Call: Scale, Flows, and Costs
See More Headlines

FHI Stock Analysis - Frequently Asked Questions

Federated Hermes' stock was trading at $52.1650 at the beginning of 2026. Since then, FHI shares have increased by 5.7% and is now trading at $55.1150.

Federated Hermes, Inc. (NYSE:FHI) announced its quarterly earnings results on Thursday, April, 30th. The company reported $1.27 EPS for the quarter, beating analysts' consensus estimates of $1.20 by $0.07. The business's quarterly revenue was up 13.1% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Federated Hermes: Federated Administrative Services, Federated Advisory Services Company, Federated Asset Management GmbH, Federated Equity Management Company of Pennsylvania, Federated Global Holdings LLC, Federated Global Investment Management Corp., Federated Holdings (UK) Limited, and more.

Federated Hermes' top institutional investors include Dimensional Fund Advisors LP (2.96%), Bank of New York Mellon Corp (0.86%), Kestra Advisory Services LLC (0.64%) and Janney Montgomery Scott LLC (0.44%). Insiders that own company stock include John B Fisher, J Christopher Donahue, Paul A Uhlman, Peter J Germain, Saker Anwar Nusseibeh, Dolores D Dudiak, Bryan M Burke, Richard A Novak and Meter Stephen Van.
View institutional ownership trends
.

Shares of FHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Federated Hermes investors own include McKesson (MCK), Bristol Myers Squibb (BMY), Chevron (CVX), Charles Schwab (SCHW), Comcast (CMCSA), Edwards Lifesciences (EW) and Toronto Dominion Bank (TD).

Company Calendar

Record date for 2/13 Dividend
2/06/2026
Ex-Dividend for 2/13 Dividend
2/06/2026
Dividend Payable
2/13/2026
Last Earnings
4/30/2026
Record date for 5/15 Dividend
5/08/2026
Ex-Dividend for 5/15 Dividend
5/08/2026
Today
5/12/2026
Dividend Payable
5/15/2026
Next Earnings (Estimated)
7/30/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
FIN - INVEST MGMT
Sub-Industry
Trading
Current Symbol
NYSE:FHI
CIK
1056288
Employees
2,091
Year Founded
1955

Price Target and Rating

High Price Target
$55.00
Low Price Target
$53.00
Potential Upside/Downside
-3.6%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
$5.16
Trailing P/E Ratio
10.85
Forward P/E Ratio
11.02
P/E Growth
2.2
Net Income
$403.30 million
Net Margins
21.47%
Pretax Margin
29.16%
Return on Equity
33.90%
Return on Assets
18.31%

Debt

Debt-to-Equity Ratio
0.29
Current Ratio
3.28
Quick Ratio
2.73

Sales & Book Value

Annual Sales
$1.80 billion
Price / Sales
2.36
Cash Flow
$5.42 per share
Price / Cash Flow
10.33
Book Value
$15.67 per share
Price / Book
3.57

Miscellaneous

Outstanding Shares
75,910,000
Free Float
72,725,000
Market Cap
$4.25 billion
Optionable
Not Optionable
Beta
0.67

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:FHI) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners